+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Aduro BioTech Inc (ADRO) - Financial and Strategic SWOT Analysis Review

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4


  • Advaxis Inc
  • Akebia Therapeutics Inc
  • Idera Pharmaceuticals Inc
  • NewLink Genetics Corp
  • MORE

Aduro BioTech Inc (Aduro BioTech) is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using proprietary technology platforms such as live, attenuated, double-deleted listeria, sting pathway activators; and B-select monoclonal antibodies to create immunotherapies for the treatment of cancers, infectious and autoimmune diseases. Its products under development are intended for the treatment of multiple indications, including pancreatic, lung, ovarian, prostate cancers, mesothelioma and glioblastoma. The company collaborates with various pharmaceutical companies to expand its products and technology platforms. Aduro BioTech is headquartered in Berkeley, California, the US.

Aduro BioTech Inc Key Recent Developments

Mar 05, 2018: Aduro Biotech Appoints Hans van Eenennaam Executive Vice President Antibody Research and Site Head, Aduro Biotech Europe
Mar 01, 2018: Aduro Biotech Reports Fourth Quarter And Full Year 2017 Financial Results
Jan 05, 2018: Aduro Biotech Announces Management Changes
Oct 31, 2017: Aduro Biotech Reports Third Quarter 2017 Financial Results
Oct 09, 2017: Aduro Biotech Announces Upcoming Data Presentations at the Society for Immunotherapy of Cancer’s 32nd Annual Meeting

This comprehensive SWOT profile of Aduro BioTech Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Aduro BioTech Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Product cover images may vary from those shown
2 of 4


  • Advaxis Inc
  • Akebia Therapeutics Inc
  • Idera Pharmaceuticals Inc
  • NewLink Genetics Corp
  • MORE
Section 1 - About the Company
  • Aduro BioTech Inc - Key Information
  • Aduro BioTech Inc - Overview
  • Aduro BioTech Inc - Key Employees
  • Aduro BioTech Inc - Key Employee Biographies
  • Aduro BioTech Inc - Key Operational Heads
  • Aduro BioTech Inc - Major Products and Services
  • Aduro BioTech Inc - History
  • Aduro BioTech Inc - Company Statement
  • Aduro BioTech Inc - Locations And Subsidiaries
  • Aduro BioTech Inc - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Aduro BioTech Inc - Business Description
  • Aduro BioTech Inc - Corporate Strategy
  • Aduro BioTech Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Aduro BioTech Inc - Strengths
  • Aduro BioTech Inc - Weaknesses
  • Aduro BioTech Inc - Opportunities
  • Aduro BioTech Inc - Threats
  • Aduro BioTech Inc - Key Competitors
Section 3 - Company Financial Performance Charts
  • Aduro BioTech Inc - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • Aduro BioTech Inc, Key Information
  • Aduro BioTech Inc, Key Ratios
  • Aduro BioTech Inc, Share Data
  • Aduro BioTech Inc, Major Products and Services
  • Aduro BioTech Inc, History
  • Aduro BioTech Inc, Key Employees
  • Aduro BioTech Inc, Key Employee Biographies
  • Aduro BioTech Inc, Key Operational Heads
  • Aduro BioTech Inc, Other Locations
  • Aduro BioTech Inc, Subsidiaries
  • Aduro BioTech Inc, Key Manufacturing facilities
  • Aduro BioTech Inc, Key Competitors
  • Aduro BioTech Inc, SWOT Analysis
  • Aduro BioTech Inc, Ratios based on current share price
  • Aduro BioTech Inc, Annual Ratios
  • Aduro BioTech Inc, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Aduro BioTech Inc, Performance Chart
  • Aduro BioTech Inc, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4


4 of 4
  • NewLink Genetics Corp
  • Idera Pharmaceuticals Inc
  • Akebia Therapeutics Inc
  • Advaxis Inc
Note: Product cover images may vary from those shown